134 related articles for article (PubMed ID: 24656402)
1. Fluctuations in eGFR in relation to unenhanced and enhanced MRI and CT outpatients.
Azzouz M; Rømsing J; Thomsen HS
Eur J Radiol; 2014 Jun; 83(6):886-892. PubMed ID: 24656402
[TBL] [Abstract][Full Text] [Related]
2. Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy?
Lacquaniti A; Buemi F; Lupica R; Giardina C; Murè G; Arena A; Visalli C; Baldari S; Aloisi C; Buemi M
Radiology; 2013 Apr; 267(1):86-93. PubMed ID: 23297321
[TBL] [Abstract][Full Text] [Related]
3. Identifying outpatients with renal insufficiency before contrast-enhanced CT by using estimated glomerular filtration rates versus serum creatinine levels.
Herts BR; Schneider E; Poggio ED; Obuchowski NA; Baker ME
Radiology; 2008 Jul; 248(1):106-13. PubMed ID: 18458249
[TBL] [Abstract][Full Text] [Related]
4. Contrast-induced acute kidney injury in cirrhotic patients. A retrospective analysis.
Safi W; Rauscher I; Umgelter A
Ann Hepatol; 2015; 14(6):895-901. PubMed ID: 26436362
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of contrast material-induced nephropathy in the era of hydration.
Balemans CE; Reichert LJ; van Schelven BI; van den Brand JA; Wetzels JF
Radiology; 2012 Jun; 263(3):706-13. PubMed ID: 22535561
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of risk factors for contrast-induced nephrotoxicity in outpatients undergoing intravenous contrast-enhanced computed tomography studies.
Carstensen M; Keer D; Rempel J; Jeon P; Barrett B
Can Assoc Radiol J; 2012 Aug; 63(3):177-82. PubMed ID: 22030305
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of patient questionnaire in predicting renal dysfunction in outpatients older than 60 years of age prior to contrast-enhanced computed tomography.
Lui EH; Lau KK; Polkinghorne K; Chang CA; Ardley N
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):168-72. PubMed ID: 22498189
[TBL] [Abstract][Full Text] [Related]
8. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU.
Ng CS; Shaw AD; Bell CS; Samuels JA
AJR Am J Roentgenol; 2010 Aug; 195(2):414-22. PubMed ID: 20651198
[TBL] [Abstract][Full Text] [Related]
9. Influence of Clinical Factors on Risk of Contrast-Induced Nephrotoxicity From IV Iodinated Low-Osmolality Contrast Material in Patients With a Low Estimated Glomerular Filtration Rate.
Ellis JH; Khalatbari S; Yosef M; Cohan RH; Davenport MS
AJR Am J Roentgenol; 2019 Nov; 213(5):W188-W193. PubMed ID: 31268731
[No Abstract] [Full Text] [Related]
10. Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) - a clinical problem in daily practice? A multicenter observational study.
Lencioni R; Fattori R; Morana G; Stacul F
Acta Radiol; 2010 Sep; 51(7):741-50. PubMed ID: 20707658
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
Solomon RJ; Natarajan MK; Doucet S; Sharma SK; Staniloae CS; Katholi RE; Gelormini JL; Labinaz M; Moreyra AE;
Circulation; 2007 Jun; 115(25):3189-96. PubMed ID: 17562951
[TBL] [Abstract][Full Text] [Related]
12. Prediction of presence of kidney disease in a general patient population undergoing intravenous iodinated contrast enhanced computed tomography.
Moos SI; Stoker J; Nagan G; de Weijert RS; van Vemde DN; Bipat S
Eur Radiol; 2014 Jun; 24(6):1266-75. PubMed ID: 24663822
[TBL] [Abstract][Full Text] [Related]
13. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.
Nyman U; Björk J; Aspelin P; Marenzi G
Acta Radiol; 2008 Jul; 49(6):658-67. PubMed ID: 18568558
[TBL] [Abstract][Full Text] [Related]
14. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
[TBL] [Abstract][Full Text] [Related]
15. Probability of reduced renal function after contrast-enhanced CT: a model based on serum creatinine level, patient age, and estimated glomerular filtration rate.
Herts BR; Schneider E; Obuchowski N; Poggio E; Jain A; Baker ME
AJR Am J Roentgenol; 2009 Aug; 193(2):494-500. PubMed ID: 19620448
[TBL] [Abstract][Full Text] [Related]
16. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure.
Kuhn MJ; Chen N; Sahani DV; Reimer D; van Beek EJ; Heiken JP; So GJ
AJR Am J Roentgenol; 2008 Jul; 191(1):151-7. PubMed ID: 18562739
[TBL] [Abstract][Full Text] [Related]
17. Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT.
Pahade JK; LeBedis CA; Raptopoulos VD; Avigan DE; Yam CS; Kruskal JB; Pedrosa I
AJR Am J Roentgenol; 2011 May; 196(5):1094-101. PubMed ID: 21512075
[TBL] [Abstract][Full Text] [Related]
18. Background fluctuation of kidney function versus contrast-induced nephrotoxicity.
Bruce RJ; Djamali A; Shinki K; Michel SJ; Fine JP; Pozniak MA
AJR Am J Roentgenol; 2009 Mar; 192(3):711-8. PubMed ID: 19234268
[TBL] [Abstract][Full Text] [Related]
19. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
Li S; Zheng Z; Tang X; Peng L; Luo Y; Dong R; Zhao Y; Liu J
J Comput Assist Tomogr; 2015; 39(6):969-74. PubMed ID: 26248154
[TBL] [Abstract][Full Text] [Related]
20. Nephrotoxic Polypharmacy and Risk of Contrast Medium-Induced Nephropathy in Hospitalized Patients Undergoing Contrast-Enhanced CT.
Ho YF; Hsieh KL; Kung FL; Wu FL; Hsieh LL; Chou H; Chen SJ
AJR Am J Roentgenol; 2015 Oct; 205(4):703-8. PubMed ID: 26397318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
